As many as 136 million adult Americans may be eligible for Ozempic, researchers estimate. According to a study published Monday in JAMA Network, among the 25,531 participants, 8,504 were eligible for semaglutide.

tag:reuters.com,2024:binary_RC2KH6A3RKV9-BASEIMAGE

The Hill

Washington

District of Columbia

United States

Researchers estimate 136M Americans eligible for Ozempic

As many as 136 million adult Americans may be eligible for Ozempic, researchers estimate. According to a study published Monday in JAMA Network, among the 25,531 participants, 8,504 were eligible for semaglutide. Semaglutide, the active medicine found in the drug, has become a popular option for people looking to lose weight. Ozempic, along with Wegovy,…

Ad Fontes Media

All Sides

Media Bias/Fact Check

Nexstar Media Group

Just a few years after some TikTok videos spiked the demand, one in eight US adults has tried Ozempic (semaglutide) or another drug in its class. Glucagon-like peptide 1 (GLP-1) receptor agonist medications have revolutionized obesity medicine. But they’re not without problems. In the early days of the social media craze, news reports often featured […]

Medscape

Side Effects of GLP-1 Drugs: What Doctors Should Know

A study by Harvard University shows that the majority of the adult population of the United States would experience health benefits from treatment with semaglutide, the active ingredient in the drugs Wegovy and Ozempic, known for...

O cercetare realizată de Universitatea Harvard arată că majoritatea populației adulte a Statelor Unite ar avea beneficii de sănătate în urma tratamentului cu semaglutidă, ingredientul activ din medicamentele Wegovy și Ozempic, cunoscute pentru faptul că…

Un studiu făcut de Universitatea Harvard arată că un număr uriaș de americani sunt eligibili pentru tratament cu Ozempic - HotNews.ro

Hot News

Romania

Harvard University study shows that a huge number of Americans are eligible for treatment with Ozempic - Hotnews.ro

US News is a recognized leader in college, grad school, hospital, mutual fund, and car rankings. Track elected officials, research health conditions, and find news you can use in politics, business, health, and education.

U.S. News

Mortimer Zuckerman

New York

More Than Half of U.S. Adults Could Be Candidates for Ozempic

A groundbreaking Harvard study reveals that semaglutide could benefit more people in the U.S. than ever imagined.

Gizmodo

G/O Media

A Staggering Number of U.S. Adults Are Eligible for Ozempic, Study Finds - WorldNL Magazine

Researchers estimate 136 million adults, or about half the U.S. adult population, are eligible for semaglutide shots like Ozempic or Wegovy. That's according to a new study published in JAMA Network on Monday, Nov. 18. Nearly 26,000 adults participated in the study, which found that 8,504 of them were eligible to receive semaglutide shots for diabetes, weight management and/or preventing cardiovascular disease. Semaglutide shots treat Type 2 dia…

Straight Arrow News

136 million US adults eligible for semaglutide shots: Study

Watch TODAY excerpt:
		 More than half of US adults are now eligible for Ozempic, Wegovy

Roberts family

Watch TODAY Clip: More than half of US adults are now eligible for Ozempic, Wegovy

technewstube.com

A Staggering Number of U.S. Adults Are Eligible for Ozempic, Study Finds

Researchers estimate that 136.8 million adults in the U.S. are eligible for semaglutide, the generic for Novo Nordisk's Ozempic, Wegovy and Rybelsus.

Researchers estimate 136M Americans eligible for Ozempic

Coverage Details

Bias Distribution

Ownership

Similar News Topics

Similar News Topics